Mental Health Crisis Among Kids Creates Dire Need for Telemedicine and Mental Health Services in Schools
NEW YORK, Nov. 24, 2021 /PRNewswire/ -- It's no secret that the ongoing global pandemic is taking a toll on mental health, but few realize how much it is affecting children, up until recently, that is. Last month, a coalition of America's leading experts in pediatric health declared a mental health crisis among children that is quickly escalating into a national emergency. The declaration calls on policymakers to make access to telemedicine and mental health care in schools a priority. Fortunately, the Biden Administration has pledged to provide nearly $85 million for mental health awareness, training, and treatment for children. The Canadian Liberal has also said previously that it will give provinces and territories $4.5 billion over five years in targeted funding for mental health. As governments turn their attention to funding, companies like Mednow Inc. (TSXV:MNOW) (OTCQB:MDNWF), Teladoc Health Inc. (NYSE:TDOC), CloudMD Software & Services Inc. (TSXV:DOC) (OTCPK:DOCRF), 1Life Healthcare, Inc. (NASDAQ:ONEM), and Well Health Technologies Corp. (TSX:WELL) (OTCPK:WLYYF) continue bolstering their virtual mental health offerings to meet the growing market need.
Mednow Inc. (TSXV:MNOW) (OTC:MDNWF) to acquire approximately 2.5% of Doko for about $500,000, with a path to 51% ownership of the company. This acquisition gives Mednow access to a network of 100 doctors in 37 countries and comes with a valuable US virtual care license, placing the company as a leader in the North American market.
In Q4 2021, Mednow achieved significant operational and financial milestones including the launch of Mednow Virtual Care to provide telemedicine services; the acquisition of Medvisit, a company that conducted about 30,000 annual patient visits; an investment agreement to acquire an equity interest in Life Support Mental Health Inc and approval of the company's pharmacy licenses from Nova Scotia College of Pharmacists, allowing the company to operate in Nova Scotia.
Mednow also announced the creation of Mednow for Business, as part of the company's institutional services business, and revealed that it is making significant moves to accelerate this business by making several executive appointments and signing a marketing services agreement with Sterling Capital Brokers.
"Through the acceleration of our institutional services business, Mednow for Business, the acquisition of Medvisit, our investment in Life Support Mental Health Inc. and the launch of Mednow Virtual Care telemedicine services, we have recently made significant strides in bolstering our service offering," said Karim Nassar, CEO of Mednow. "With over $28 million in cash as of July 31, 2021 we remain in a strong financial position to continue executing on our strategic plan."
Mednow also announced that it has received confirmation from The Depository Trust Company DTC that its common shares are eligible for electronic clearing and settlement through DTC in the US facilitating trading on the OTCQB exchange.
For more information on Mednow Inc. (TSXV:MNOW) (OTC:MDNWF), click here.
More Patients Access Mental Health Care through Virtual Care Platforms
Teladoc Health Inc. (NYSE:TDOC) continues to deliver access to healthcare with the expansion of Primary360, the company's primary care service. Primary 360 will now be available to commercial health plans, employers, and organizations that sponsor healthcare for families and individuals. Pilot programs of the service have shown that a majority of the people without traditional primary care are benefiting from physician-led care teams, and helped in the screening, detection, and treatment of previously undiagnosed conditions including mental health problems.
CloudMD Software & Services Inc. (TSXV:DOC) (OTC:DOCRF) partnered with an additional 19 post-secondary institutions in Canada to provide more than 167,000 students with its Aspiria Student Assistance Program. CloudMD is partnering with these colleges and universities to provide them with the resources to support the growing demand for mental health care as students deal with the impact of the pandemic. Aspiria SAP is an integrated mental health service that comes with digital tools for assessment, triaging, and short-term counseling. The service is accessible to students 24/7 all year round to support students' mental health needs when and as they arise.
1Life Healthcare, Inc. (NASDAQ:ONEM) extended its reach to children and adults with the acquisition of Iora Health. This acquisition places One Medical in a better position to deliver better health, care, and affordability for patients in all stages of life from children to adults. After completing the acquisition, Iora Primary Care has been added to Cigma's Medicare Advantage Network in Maricopa County Arizona. Through this addition, customers in all Cigma's MA plans in Maricopa County can access Iora's 12 primary care practices in Maricopa County.
Well Health Technologies Corp. (TSX:WELL) (OTC:WLYYF) saw a 72% increase in mental health visits in Q3 2021 in its primary care business in Canada. Most of these visits (68%) were virtual care visits. This increase comes as Well Health expands its portfolio of virtual health care tools and technology allowing practitioners to deploy behavioral health care services to meet the growing demand. The company has also expanded its initiative after WELL Ventures, a subsidiary of Well Health, invested in Hasu Behavioral Health, a virtual online therapy clinic that supports individuals and families dealing with mental health issues including anxiety, depression, trauma, substance abuse, and relationship problems.
The isolation and uncertainties of the pandemic have led to skyrocketing mental health issues among children and young people as well as adults. The declining stigma towards mental health issues and the growing penetration of telehealth services have seen more people access services from telehealth providers like Mednow Inc.
PAID ADVERTISEMENT. This communication is a paid advertisement for Mednow Inc. ("Mednow" or the "Company") to enhance public awareness of the Company, its products, its industry and as a potential investment opportunity. NativeAds, Inc. ("NativeAds") and its owners, managers, employees, and assigns were paid by the Company to create, produce and distribute this advertisement, as previously disclosed in the news release of the Company dated March 12, 2021. This compensation should be viewed as a major conflict with NativeAds' ability to be unbiased.
This communication is not intended as, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this communication nor the Company purport to provide a complete analysis of the Company or its financial position. The Company is not, and does not purport to be, a broker-dealer or registered investment adviser. This communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the Company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the profiled company's SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk.
This communication is based on information generally available to the public and on and does not contain any material, non-public information.
FORWARD-LOOKING STATEMENTS. This communication includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws, including statements regarding the timing of operations beginning in Manitoba, Saskatchewan and Nova Scotia, receipt of all required regulatory approvals from the Manitoba College of Pharmacists, the Nova Scotia College of Pharmacists and other regulatory bodies with oversight of pharmacy practices, the ability to service clients in Saskatchewan and Manitoba from the Manitoba fulfillment centre, the ability to service clients in Nova Scotia from the Nova Scotia fulfillment centre and the benefits of a national presence. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends," "anticipates," "it is expected," or variations of such words and phrases, or statements that certain actions, events or results "may," "could," "should," or "would" occur. Forward-looking statements are based on certain material assumptions and analyses made by management of the Company and the opinions and estimates of management of the Company as of the date of this communication, including that the transactions contemplated herein will close on the terms and timeline as anticipated by the management of the Company and that the Company will receive all required regulatory approvals. Although the Company considers these assumptions to be reasonable based on information currently available to them, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such risk factors may include, among others, the risk that the transactions contemplated herein will not close on the terms and timeline as anticipated by the management of the Company, or at all, the risk that the Company will not receive required regulatory approvals and the other risks and uncertainties applicable to the Company and the business of the Company as set forth in the Company's final long form prospectus dated February 26, 2021 and its other disclosure available under the Company's profile at www.sedar.com. There can be no assurance that the transactions contemplated in this communication will complete. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affections such statements and information other than as required by applicable laws, rules and regulations. We seek safe harbor.
RELEASE OF LIABILITY. By reading this communication, you acknowledge that you have read and understand this disclaimer, and further that to the greatest extent permitted under law, you release the Company, its affiliates, assigns and successors from any and all liability, damages, and injury from this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.
Disclaimer: Microsmallcap.com (MSC) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MSC or any company mentioned herein. The commentary, views and opinions expressed in this release by MSC are solely those of MSC and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MSC and FNM for any investment decisions by their readers or subscribers. MSC and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author (MSC), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (MSC) has not independently verified or otherwise investigated all such information. None of the Author, MSC, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated twenty five hundred dollars by MSC, a non-affiliated third party to distribute this release on behalf of Mednow Inc. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
FN Media Group, LLC
Upcoming Life Sciences Events
- December 2021
- BioFIT - Fostering Innovation & Transfer
- MedFIT - Fostering Innovation in MedTech
- January 2022
- San Francisco: J.P. Morgan 40th Annual Healthcare Conference